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BRIEF DEFINITIVE REPORT
        Increased intestinal epithelial permeability and 
luminal antigen leakage across the barrier has 
been linked to chronic mucosal infl  ammation 
and infl  ammatory bowel disease (IBD) in ani-
mals and humans. In certain mouse models of 
IBD, including Samp-Yit (  1  ), enhanced per-
meability has been shown to predate the onset 
of intestinal infl  ammation. In humans, the two 
most common forms of IBD, Crohn  ’  s disease and 
ulcerative colitis, have been linked to an ab-
normal cell-mediated immune reaction to en-
teric bacterial antigens in genetically susceptible 
hosts (  2  ) with enhanced mucosal permeability 
(  3, 4  ). Thus, there is strong evidence for a link 
between the regulation of paracellular permea-
bility and intestinal infl  ammation. 
  Paracellular permeability is regulated by the 
apical most intercellular junction referred to as the 
tight junction (TJ), which functions as a semi-
permeable gate to regulate passive movement 
of luminal fl  uid and molecules between epithelial 
cells. The molecular composition of the TJs is 
complex, consisting of multiple transmembrane 
proteins including claudin family members, oc-
cludin, and members of the Junctional Adhesion 
Molecule (JAM) protein family. Of the JAM 
family members, several studies have implicated 
JAM-A in the regulation of barrier function and 
the infl  ammatory response. This single-pass trans-
membrane protein is expressed in several cell types 
but is particularly abundant in epithelial and 
endothelial cells, where it accumulates at TJs (  5  ). 
  Although unifying mechanistic studies are 
lacking, JAM-A has been reported to infl  uence 
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  Recent evidence has linked intestinal permeability to mucosal infl  ammation, but molecular 
studies are lacking. Candidate regulatory molecules localized within the tight junction (TJ) 
include Junctional Adhesion Molecule (JAM-A), which has been implicated in the regula-
tion of barrier function and leukocyte migration. Thus, we analyzed the intestinal mucosa 
of JAM-A  –  defi  cient (JAM-A       /      ) mice for evidence of enhanced permeability and infl  am-
mation. Colonic mucosa from JAM-A       /       mice had normal epithelial architecture but in-
creased polymorphonuclear leukocyte infi  ltration and large lymphoid aggregates not seen in 
wild-type controls. Barrier function experiments revealed increased mucosal permeability, 
as indicated by enhanced dextran fl  ux, and decreased transepithelial electrical resistance in 
JAM-A       /       mice. The in vivo observations were epithelial specifi  c, because monolayers of 
JAM-A       /       epithelial cells also demonstrated increased permeability. Analyses of other TJ 
components revealed increased expression of claudin-10 and -15 in the colonic mucosa of 
JAM-A       /       mice and in JAM-A small interfering RNA  –  treated epithelial cells. Given the 
observed increase in colonic infl  ammation and permeability, we assessed the susceptibility 
of JAM-A       /       mice to the induction of colitis with dextran sulfate sodium (DSS). Although 
DSS-treated JAM-A       /       animals had increased clinical disease compared with controls, 
colonic mucosa showed less injury and increased epithelial proliferation. These fi  ndings 
demonstrate a complex role of JAM-A in intestinal homeostasis by regulating epithelial 
permeability, infl  ammation, and proliferation. 3068 JAM-A REGULATES INTESTINAL BARRIER FUNCTION | Laukoetter et al.
mesenteric lymph nodes and spleen were performed to deter-
mine if there were diff  erences in T cell, monocyte, or DC 
activation between JAM-A       /       and WT controls. No diff  er-
ences were observed in the frequencies of nonactivated T 
cells expressing low levels of CD44 and CD69 and high lev-
els of CD62L. In addition, no diff  erences in the expression 
patterns of the co-stimulation markers CD40 and CD80 and 
I-Ab were observed in populations of CD11b  +   and CD11c  +   
cells (unpublished data). Given the reports of JAM protein  –
  mediated regulation of permeability, we reasoned that these 
histologic fi  ndings could be secondary to increased local im-
mune cell activation from luminal antigens driving the iso-
lated lymphoid follicle hyperplasia within the colonic mucosa 
of JAM-A       /       mice. This appears to be a process localized to 
colonic mucosa, because we did not observe activation within 
systemic lymphoid tissues. 
  Because PMN infi  ltration could be expected under con-
ditions of increased mucosal permeability to luminal contents, 
we assayed the colonic mucosa of JAM-A       /       and WT mice 
for evidence of acute infl  ammation. As shown in   Fig. 1 D  , a 
representative mucosal section demonstrated increased num-
bers of LY-6G  –  staining PMN (  16  ) in the subepithelial lamina 
propria in JAM-A       /       mice compared with WT littermate 
controls (  n   = 6). No crypt abscesses were observed. Consistent 
with the LY-6G staining results, myeloperoxidase (MPO) ac-
tivity of colonic mucosa was signifi  cantly increased in JAM-
A       /       mice versus controls (  n   = 6;   Fig. 1 E  ). These fi  ndings 
demonstrate increased infi  ltration of acute infl  ammatory cells 
in the colonic mucosa of JAM-A       /       mice. 
  Interestingly, JAM-A       /       mice have been reported to have 
reduced PMN and increased monocyte infi  ltration of tissues 
after ischemic injury (  17  ) that was not seen in mice with 
endothelial-specifi  c loss of JAM-A, suggesting that leukocyte-
expressed JAM-A may play a role in PMN recruitment. 
On the contrary, our fi  ndings demonstrate elevated PMN 
infi  ltration of colonic mucosa in JAM-A       /       mice, which would 
be consistent with the enhanced recruitment of leukocytes 
caused by leakage of luminal chemoattractants across a more 
permeable epithelium. 
  JAM-A regulates intestinal mucosal permeability in vivo 
  Given the increased colonic infl  ammation noted in JAM-
A       /       mice, we performed experiments to determine if there 
was increased mucosal permeability. Consistent with previ-
ous in vitro studies suggesting a role of JAM-A in the regula-
tion of epithelial and endothelial permeability (  5, 8, 18  ), 
small interfering RNA (siRNA)  –  mediated knockdown of 
JAM-A protein in human SK-CO15 colonic epithelial cells 
decreased TER (    60% decrease; P   <   0.05;   Fig. 2 A  ) com-
pared with controls.   We next performed in vivo experi-
ments assessing gut barrier function in JAM-A       /      . Initial 
physiologic experiments demonstrated enhanced permeabil-
ity to ingested labeled dextran. As shown in   Fig. 2 B  , gastro-
intestinal permeability, as determined by serum FITC-dextran 
concentration (ng/ml) 4 h after gavage, was markedly in-
creased in JAM-A       /       mice compared with controls (  n   = 6 
several cellular processes, including regulation of paracel-
lular permeability, cell polarity, cell adhesion, cell migration, 
angiogenesis, and leukocyte migration (  6  –  10  ). We previ-
ously reported in vitro evidence of a role for JAM-A in 
the regulation of epithelial barrier function by demon-
strating enhanced permeability to dextran and decreased 
transepithelial electrical resistance (TER) after JAM-A knock-
down (  8  ). Detailed in vivo permeability studies in JAM-A  – 
defi  cient (JAM-A       /      ) mice are lacking, although there is 
one report of enhanced corneal permeability in JAM-A       /       
animals (  11  ). 
  Because it is not known whether JAM-A plays a direct 
role in the regulation of epithelial permeability and the 
mucosal infl  ammatory response, we performed a series of 
in vivo and in vitro experiments using JAM-A       /       mice and 
cultured human intestinal epithelial cells. In this report, we 
show that JAM-A defi  ciency results in increased colonic in-
flammation and paracellular permeability in parallel with 
altered expression of claudin-10 and -15, both of which 
regulate TJ barrier function (  12  ) by formation of ion-selective 
pores composed of homo- and heterooligomers (  13  –  15  ). 
We also report that JAM-A       /       mice have increased suscep-
tibility to experimentally induced colitis in conjunction with 
enhanced epithelial proliferation. 
    RESULTS AND DISCUSSION   
  JAM-A defi  ciency in mice results in enhanced 
colonic infl  ammation 
  A widely accepted hypothesis as to the mechanism of chronic 
relapsing intestinal infl  ammation in IBD is that gut epithelial 
barrier dysfunction permits luminal antigens to enter the sub-
epithelial tissues, resulting in the recruitment and activation 
of leukocytes. Because JAM-A has been implicated in both 
the regulation of barrier function and leukocyte recruitment, 
we performed histological analyses of colonic mucosa from 
JAM-A       /       mice to determine if there was evidence of in-
creased infl  ammation, presumably in response to altered bar-
rier function. Despite having normal epithelial architecture, 
JAM-A       /       mice had signifi  cantly increased small (30 vs. 7 
aggregates   <  1 mm in JAM-A       /       vs. control (WT littermate) 
mice, respectively;   Fig. 1 A  ) and large (5 vs. 0 aggregates   ≥  1 mm 
in JAM-A       /       vs. control mice, respectively;   Fig. 1 B  ) lym-
phoid aggregates in the distal colon (three sections per mouse; 
  n   = 7 mice; P   <   0.05).   
  As shown in   Fig. 1 B  , the lymphoid structures contained 
mostly B lymphocytes marking for B220 PE and T cells 
marking for Thy 1.2 APCs that were mostly CD4  +   (not de-
picted), which was consistent with isolated lymphoid follicles. 
Of note, many large isolated lymphoid follicles were local-
ized below the muscularis mucosae (  Fig. 1 C  ), which was not 
seen in any WT mice. These lymphoid aggregates contained 
abundant B cells (B220 PE) and DCs (CD1lc). Examination 
of small intestines from JAM-A       /       and WT animals revealed 
no signifi  cant diff  erences in the numbers of isolated lymphoid 
follicles or histology between the groups (unpublished data). 
Flow cytometric analyses of leukocytes derived from the JEM VOL. 204, December 24, 2007  3069
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    Figure 1.         Increased colonic infl  ammation in JAM-A      /      mice.   (A) Increased small lymphoid aggregates in JAM-A      /      mice. (B) Large lymphoid aggre-
gates in JAM-A      /      mice  identifi  ed as isolated lymphoid follicles. (C) Large, isolated submucosal lymphoid follicles observed only in JAM-A      /      mice.  CD11c 
staining is shown in red. (D) Increased PMN in the colonic mucosa of JAM-A     /     mice. Bars, 40      m. (E) MPO activity in the colonic mucosa of JAM-A      /     
mice and littermate controls (  n   = 6). Horizontal bars represent the mean.     3070 JAM-A REGULATES INTESTINAL BARRIER FUNCTION | Laukoetter et al.
  JAM-A defi  ciency results in enhanced expression 
of claudin-10 and -15 in vitro and in vivo 
  Because TJs regulate intestinal epithelial permeability, we ex-
amined whether the loss of JAM-A resulted in altered expres-
sion of TJ structural proteins. Although JAM-A per se has not 
been shown to directly form a selective barrier in transfected 
cells, recent studies have implicated a direct role of claudin 
proteins in regulating TJ permeability to water and ions (  19–21  ). 
We thus assessed if the loss of JAM-A was associated with al-
tered claudin expression. Monolayers of SK-CO15 cells were 
transfected with siRNA specifi  c for JAM-A or control siRNA 
and surveyed for the altered expression of claudins. As shown 
in   Fig. 3 A  , Western blots of cells treated with JAM-A siRNA, 
but not lamin A/C or scramble controls, showed a 70  –  90% re-
duction in JAM-A protein along with signifi  cant up-regulation 
of claudin-10 and -15 and no change in occludin or claudin-2 
levels.   These fi  ndings show a role for JAM-A in the regulation 
of claudin expression. 
  To verify the physiologic relevance of the in vitro fi  ndings, 
we analyzed the protein levels of claudin-10 and -15 in distal 
colonic mucosal samples from JAM-A       /       mice. Consistent 
with the fi  ndings in   Fig. 3 A  , Western blots of colonic mucosal 
epithelial cell lysates from JAM-A       /       mice showed signifi  cant 
up-regulation of claudin-10 and -15 compared with controls, 
with no change in occludin or claudin-2 (  Fig. 3 B  ). Densito-
metric analyses revealed 3.5- and 7.5-fold up-regulation of 
expression of claudin-10 and -15, respectively (  Fig. 3 C  ). 
As shown in   Fig. 3 (D  –  G)  , immunofl  uorescence analyses of 
animals per condition). To better defi  ne the barrier defect, 
we next performed ex vivo permeability studies on colonic 
mucosa mounted in Ussing chambers. As shown in   Fig. 2 C  , 
there was increased fl  ux of FITC-dextran (2 vs. 0.25   μ  g/h/cm  2  ) 
across the colonic mucosa of JAM-A       /       mice (  n   = 5 mice 
per condition; P   <   0.05). In parallel, there was also decreased 
TER (  Fig. 2 D  ) in mucosal tissue samples of JAM-A       /       
mice compared with controls. Interestingly, we did not ob-
serve enhanced translocation of bacteria to the mesenteric 
lymph nodes and spleen in JAM-A       /       mice compared with 
controls (unpublished data), suggesting that the permeability 
defect is not suffi   cient to aff  ord increased translocation of 
bacteria while permitting passage of smaller molecules. In 
addition, the absence of increased bacterial translocation in 
JAM-A       /       mice is consistent with our observation of a lack 
of systemic immune activation. These data thus provide 
direct evidence of JAM-A regulation of intestinal mucosal 
permeability in vivo. Indeed, the results of other studies 
with JAM-A       /       mice can be interpreted to support our 
fi  ndings. Cera et al. reported enhanced immune responses to 
antigens painted on the skin of JAM-A       /       mice secondary 
to the enhanced motility of DCs (  10  ). However, the possi-
bility of increased antigen exposure secondary to a leaky skin 
barrier was not addressed. In addition, Kang et al. recently 
reported that corneal epithelial permeability in JAM-A       /       
animals is increased (  11  ). Collectively, these data suggest a 
central role of JAM-A in the regulation of the epithelial bar-
rier in vivo. 
    Figure 2.         JAM-A defi  ciency results in enhanced intestinal permeability in vivo and in vitro.   (A) TER of SK-CO15 cells after transient transfection 
with JAM-A siRNA. *, P  <   0.05. (B) In vivo gastrointestinal permeability in control and JAM-A      /      mice 4 h after FITC-dextran gavage. Horizontal bars repre-
sent mean. (C) FD-4 fl  ux across colonic mucosal sheets of WT and JAM-A      /      mice  ( n   = 5 each). *, P   <   0.05. Error bars in A and C represent the mean   ±   SEM. 
(D) Resistance across colonic mucosal sheets for JAM-A      /      mice and WT littermate controls (  n   =  5).   JEM VOL. 204, December 24, 2007  3071
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    Figure 3.         JAM-A defi  ciency results in altered claudin expression in vitro and in vivo.   (A) Claudin protein expression profi  les after JAM-A siRNA 
transfection in vitro. (B) Colonic mucosal claudin protein expression profi  les in vivo from JAM-A      /      mice. (C) Densitometric analysis of claudin and occludin 
expression from Western blots obtained from WT and JAM-A      /      mice  ( n   = 5 each). *, P   <   0.05. (D  –  G) Immunofl  uorescence images of claudin-10 and -15, 
occludin, and claudin-2 expression in the colonic mucosa of WT and JAM-A      /      mice. ***, P   <   0.0001. Error bars represent the mean   ±   SEM. Bars, 40     M.   3072 JAM-A REGULATES INTESTINAL BARRIER FUNCTION | Laukoetter et al.
and morphologic grading of infl  ammation in experimental 
groups. Interestingly, DSS-induced colonic MPO activity in 
JAM-A       /       mice, although increased compared with non  –
  DSS-treated mice, was less than that in DSS-treated WT ani-
mals. A possible explanation includes desensitization of PMN 
because of enhanced exposure to microbial products in a 
more permeable mucosa. Alternatively, there may simply be 
a decreased availability of PMN for migration into the gut 
because of increased baseline PMN recruitment into tissues, 
as evident in   Fig. 1 (D and E)  . Lastly, as others have pro-
posed, there may be leukocyte-specifi  c eff  ects of JAM-A that 
aff  ect recruitment. 
  By standard blinded histological scoring parameters, the 
colonic mucosa of control mice had minimal infl  ammation 
(  Fig. 4 E  ), however, DSS treatment resulted in a markedly 
increased score (  Fig. 4 E  ). In WT C57BL/6 littermates, in-
fl  ammation was mainly confi  ned to the mucosa with a loss of 
goblet cells, crypt damage, prominent mucosal ulceration, and 
edema (  Fig. 4 F  ). Surprisingly, despite worse clinical scores, 
DSS-treated JAM-A       /       mice showed less severe injury and 
less edema than controls (2.66 ± 0.943 [SD] vs. 4.04 ± 0.68 [SD] 
for JAM-A       /       vs. WT controls, respectively; P   <   0.007). 
Reduced edema in the JAM-A       /       animals suggests less endo-
thelial leakiness; however, we also observed less ulceration 
and a prominent epithelial regenerative response characterized 
by an increase in goblet cells (  Fig. 4 F  ). 
  Increased intestinal epithelial cell proliferation 
in JAM-A      /      mice 
  Given the regenerative phenotype observed in the colonic 
mucosa of DSS-treated JAM-A       /       mice, we assessed epithe-
lial proliferation in adjacent mucosal sections. Segments of the 
distal colon of control and JAM-A       /       mice were stained for 
Ki-67, a nuclear protein preferentially expressed during active 
phases of the cell cycle (G  1  , S, G  2  , and M phases) that is absent 
in resting (G  0  ) cells (  25  ). Proliferating Ki-67  –  staining epithe-
lial cells are normally restricted to the crypt region, as is seen 
in   Fig. 5 A   for control mice.   However, in JAM-A       /       mice, 
Ki-67 staining extends from crypts toward the lumen along 
the normally quiescent crypt-to-surface axis (  Fig. 5 A  ). 
Immunolabeling of colonic mucosal sections for the epithelial-
specifi  c marker      -catenin demonstrated that the Ki-67 cells 
were epithelial cells (  Fig. 5 B  ). Similar increases in BrdU la-
beling were observed in JAM-A       /       colonic mucosa (unpub-
lished data). In DSS-treated WT mice, Ki-67 staining was 
decreased compared with controls but was still increased in 
JAM-A       /       mice treated with DSS. However, Ki-67 staining 
levels did not appear to be increased above the untreated val-
ues in JAM-A       /       animals, suggesting altered regulation of 
proliferative responses (  Fig. 5 B  ). It is possible that enhanced 
proliferation in JAM-A       /       animals results in a more rapid fi  ll-
ing of epithelial defects and, hence, the improved histology 
scores observed in DSS-exposed JAM-A       /       mice. 
  In summary, these fi  ndings provide direct evidence for 
JAM-A  –  mediated regulation of intestinal epithelial barrier 
function through claudin expression and proliferation that, in 
claudin expression in adjacent colonic mucosal sections from 
JAM-A       /       mice and controls performed at equivalent intensity/
gain levels confi  rmed signifi  cant up-regulation of claudin-10 
and -15 expression within the crypt epithelium in JAM-A       /       
mice, with no change in the levels of claudin-2 or occludin 
compared with controls. Similar increases in claudin-10 and 
-15 were observed in the colonic mucosa of dextran sulfate 
sodium (DSS)  –  treated JAM-A       /       mice compared with DSS-
treated WT controls (unpublished data). 
  Interestingly, claudin-10 and -15 have been reported to 
form a   “  leaky  ”   barrier in certain tissues (  19, 20  ), which is 
consistent with our observations of increased permeability 
and claudin expression in JAM-A       /       mice. Thus, we propose 
that the altered claudin expression observed may confer the in-
crease in permeability of colonic mucosa in JAM-A       /       mice. 
Indeed, it is well documented that alterations in the ratios of 
claudins expressed by epithelial cells can have dramatic eff  ects 
on the permeability to small molecules (  12, 21  ). In this paper 
and a previous one, we observed no changes in the levels of other 
apical junctional complex proteins, such as occludin, zonula 
occludens 1, and E-cadherin, after loss of JAM-A expression (  8  ). 
We speculate that the permeability defect observed is caused 
by changes in the claudin expression within TJ and not to 
gross changes in structure or assembly. Despite these observa-
tions, the cell-biological mechanism by which JAM-A mediates 
such changes in claudin protein levels remains to be determined. 
However, our fi  ndings suggest that complex regulation of pro-
tein expression may be involved, perhaps at the transcriptional 
level. These data demonstrate a mechanism for JAM-A  – 
mediated regulation of epithelial paracellular permeability in 
vivo and a plausible link to regulation of infl  ammation and 
luminal antigen exposure. 
  Increased susceptibility to infl  ammation in JAM-A      /      mice 
challenged with DSS 
  We found it surprising that the JAM-A       /       animals had evi-
dence of a B cell  –  rich isolated lymphoid follicle hyperplasia 
and increased permeability without any clinical evidence of 
colitis. Indeed, others have recently demonstrated an impor-
tant role of B cell populations in triggering and potentiating 
IBD in mice (  22, 23  ). These fi  ndings led us to predict that 
JAM-A       /       mice would have enhanced susceptibility to ex-
perimentally induced colitis. We thus used a well-established 
model of acute colitis using DSS (  24  ) in JAM-A       /       mice and 
WT littermates. Mice (  n     ≥   7) were supplemented with 5% DSS 
in the drinking water for 7 d. All mice survived until their 
time of death, and drinking volume was similar (unpublished 
data). As shown in   Fig. 4 (A and B)  , DSS-treated JAM-A       /       
mice had signifi  cantly increased disease activity index (DAI) and 
decreased body weight compared with controls (P   <   0.05).   
Furthermore, DSS-treated JAM-A       /       mice had increased 
colonic shortening (P   <   0.05;   Fig. 4 C  ) and fecal blood loss 
(not depicted) compared with controls. As expected, DSS 
treatment increased MPO activity in the colons of JAM-A       /       
mice compared with controls receiving water alone (  Fig. 4 D  ). 
Furthermore, MPO activity correlated closely with clinical JEM VOL. 204, December 24, 2007  3073
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    Figure 4.         JAM-A defi  ciency increases susceptibility to DSS-induced colitis.   (A) DAI. *, P   <   0.05, increase in DSS treatment compared with mice 
plus water per os (po) beginning at day 2; **, P   <   0.05, increase in JAM-A plus DSS treatment compared with WT and JAM  +/      plus DSS starting at day 2. 
(B) Percent weight change. *, P   <   0.05, DSS treatment compared with mice plus water po; **, P   <   0.05, JAM-A plus DSS treatment compared with WT and 
JAM  +/     plus DSS. (C) Colon weight/length ratio. *, P   <   0.05 versus control mice; **, P   <   0.05 versus WT plus DSS po. (D) Colonic MPO activity. *, P   <   0.05 
versus mice plus water po; **, P   <   0.05 versus WT control mice. (E) Histology score. *, P   <   0.05 versus water po; **, P   <   0.05 versus WT plus DSS po. 
Error bars represent the mean   ±   SEM. (F) Colonic hematoxylin and eosin staining. Note the less crypt injury/ulceration and the abundance of goblet cells 
in JAM-A      /      mice compared with control (arrows). Bars: (left) 250      m; (right) 50     m.   3074 JAM-A REGULATES INTESTINAL BARRIER FUNCTION | Laukoetter et al.
scraped into a standard lysis buff  er containing 1% TX-100 and a protease 
inhibitor cocktail (1:100; Sigma-Aldrich). PAGE and immunoblotting were 
conducted by standard protocol with 10  –  20   μ  g of total equalized protein. 
  Antibodies.     Primary antibody suppliers were as follows:      -catenin, occludin, 
claudin-1, claudin-2, claudin-5, claudin-10, claudin-15, and anti  –  human 
JAM-A (Invitrogen); goat-biotinylated polyclonal antibody against mouse 
JAM-A (R  &  D Systems); and fl  uorophore-conjugated secondary antibodies 
(Alexa dyes; Invitrogen). Horseradish peroxidase (HRP)  –  conjugated sec-
ondary antibodies were purchased from Jackson ImmunoResearch Labora-
tories. HRP-conjugated streptavidin was obtained from Invitrogen. Both 
claudin-10 and -15 have two isoforms, both of which are recognized by the 
antibodies used. 
  Mice.     All experimental protocols used either C57BL/6 (WT) mice (The 
Jackson Laboratory) or JAM-A       /       mice (a gift from T. Sato, Cornell Uni-
versity, New York, NY) and littermate controls, respectively. JAM-A       /       
mice were produced as previously described (  10  ) and were backcrossed for 
turn, regulates mucosal infl  ammation and responses to acute 
epithelial injury. More work is needed to determine the mo-
lecular basis of JAM-A regulation of TJ function and cellular 
proliferation and diff  erentiation. Furthermore, given the ob-
served diff  erential epithelial and infl  ammatory responses to 
acute colonic injury in JAM-A       /       mice, studies with tissue-
targeted deletion of JAM-A may help to delineate the mech-
anisms of JAM-A function in various cells and tissues. 
  MATERIALS AND METHODS 
  Cell culture, transfection, and immunoblotting.     SK-CO15 human co-
lonic epithelial cell lines were cultured as previously described (  8  ). For siRNA 
transfection, siRNA (siGENOME SMARTpool) for human JAM-A, cy-
clophilin B, and a scramble control were purchased from Dharmacon. Each 
transfection was performed at least three times. SK-CO15 monolayers were 
    Figure 5.         Increased epithelial proliferation in the colonic mucosa of JAM-A      /      mice.   (A)  Immunofl  uorescence labeling profi  le for Ki-67 in JAM-A      /     
and WT mice before and after treatment with DSS. Ki-67 is shown in green and nuclei are shown in blue. (B) Ki-67–positive cells (green) costained with 
the epithelial cell marker      -catenin (red) and cell nuclei (blue). The inset highlights individual Ki-67–positive epithelial cells. Bars, 40      M. (C) Analysis of the 
percentage of proliferating epithelial cells (three tissue sections stained per animal;   n   = 5 per group; *, P   <   0.05. Error bars represent the mean   ±   SEM.     JEM VOL. 204, December 24, 2007  3075
BRIEF DEFINITIVE REPORT
as previously described (  29  ). Samples were mounted between the two 
halves of the Ussing chamber (1.12-cm  2   opening). The mucosal and serosal 
sides of chambers (5ml vol) were connected to circulating reservoirs contain-
ing 37  °  C Ringer  ’  s solution and 5 mM mannitol. A gas lift column of 95% 
O  2  , 5% maintained oxygenation and pH 7.4 of the reservoirs.   I    sc   was contin-
uously monitored on a strip chart recorder, and electrical resistance (  Ω     ×   
cm  2  ) was calculated using Ohm  ’  s law from   Δ  V and   I    sc  . After baseline poten-
tial diff  erence and resistance were measured, 4-kD FITC-dextran (Sigma-
Aldrich) was added to the mucosal side of the Ussing chamber to achieve a 
fi  nal concentration of 0.01 mM. Permeability was determined after removal 
of medium from serosal compartments at the end of the 180-min experi-
mental period and assessed for fl  uorescence in a microplate fl  uorescence 
reader (FL-500; BIO-TEK) at an excitation wavelength of 485 nm and an 
emission wavelength of 530 nm. 
  Data analysis.     Results are expressed as means   ±   SEM. p-values were calcu-
lated using a multifactorial analysis of variance test and an independent   t   test. 
P   <   0.05 was considered signifi  cant. 
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